Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · IEX Real-Time Price · USD
0.400
+0.031 (8.40%)
At close: Jul 2, 2024, 4:00 PM
0.387
-0.013 (-3.25%)
After-hours: Jul 2, 2024, 7:45 PM EDT

Aligos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018
Market Capitalization
3050415061,054-
Upgrade
Market Cap Growth
97.59%21.95%-91.93%-52.00%--
Upgrade
Enterprise Value
-72-75-73329823-104
Upgrade
PE Ratio
--0.57-0.42-3.94-9.71-
Upgrade
PS Ratio
2.183.202.93116.05--
Upgrade
PB Ratio
0.500.540.392.744.79-
Upgrade
P/FCF Ratio
-0.93-0.63-0.51-4.34-13.81-
Upgrade
P/OCF Ratio
-0.93-0.63-0.51-4.37-14.19-
Upgrade
EV/Sales Ratio
-2.05-4.82-5.2275.57--
Upgrade
EV/EBITDA Ratio
0.340.880.77-2.64-8.712.01
Upgrade
EV/EBIT Ratio
0.330.850.74-2.57-8.411.92
Upgrade
EV/FCF Ratio
0.360.950.90-2.83-10.782.10
Upgrade
Debt / Equity Ratio
0.180.120.120.080.06-0.22
Upgrade
Debt / EBITDA Ratio
-0.13-0.13-0.13-0.12-0.14-0.28
Upgrade
Debt / FCF Ratio
-0.13-0.14-0.16-0.12-0.17-0.29
Upgrade
Quick Ratio
5.985.683.804.908.068.55
Upgrade
Current Ratio
6.255.904.035.258.268.70
Upgrade
Asset Turnover
0.120.130.080.0200
Upgrade
Interest Coverage
-6.87----9.28-
Upgrade
Return on Equity (ROE)
-144.20%-116.40%-74.50%-67.00%-139.90%132.90%
Upgrade
Return on Assets (ROA)
-84.50%-75.40%-54.60%-54.30%-52.70%-41.10%
Upgrade
Return on Capital (ROIC)
-122.73%-85.38%-83.78%-64.42%-41.98%106.89%
Upgrade
Earnings Yield
-331.88%-176.22%-235.41%-25.37%-10.30%-
Upgrade
FCF Yield
-264.73%-158.81%-196.90%-23.04%-7.24%-
Upgrade
Buyback Yield / Dilution
-263.91%-50.51%-7.13%-299.03%-397.62%81.93%
Upgrade
Total Shareholder Return
-263.91%-50.51%-7.13%-299.03%-397.62%81.93%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).